SignatureFD’s Astria Therapeutics ATXS Stock Holding History

SignatureFD’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20	Closed	-$262	–	3477
2025 Q4	$262	Hold	20	–	–	﹤0.01%	3281
2025 Q3	$146	Buy	+20	New	+$135	﹤0.01%	3303
2025 Q2	–	Sell	-241	Closed	-$1.29K	–	3267
2025 Q1	$1.29K	Buy	+241	New	+$1.69K	﹤0.01%	2988

SignatureFD's ATXS Position: Q1 2026 in Review

SignatureFD sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 20 shares — an estimated $262 sold.

SignatureFD first reported a position in ATXS in Q1 2025 and held it in 3 quarters. The position peaked at $1.29K in Q1 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

SignatureFD reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
SignatureFD sold 20 Astria Therapeutics shares in Q1 2026, an estimated $262.
SignatureFD first reported a position in Astria Therapeutics in Q1 2025 and held it in 3 quarters.
SignatureFD's Astria Therapeutics position peaked at $1.29K in Q1 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.